Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
with an annual turnover of £1.35 billion, a significant ongoing capital investment programme, 12,800 staff and over 46,000 students from 190 countries. We are a truly global institution, with a long
-
for Humanity. What you would be doing: Research – As a part of the Dyson School of Design Engineering, you will actively develop and lead your own research programme, in line with our research themes and vision
-
research spaces for academics and their collaborators. In addition, the University of Birmingham offers exceptional High Performance Computing facilities, including through the Tier-2 Baskerville system
-
/travel discounts, access to our Employee Assistant Programme Scheme, Health and Wellbeing Support and a salary sacrifice cycle to work scheme. Please follow this link to find out more - Benefits How to
-
experienced biophysicist/computational chemist to join our liquid phase electron microscopy team to develop molecular dynamics simulations of cryo-EM and LPEM maps to inform our experimental observations, as
-
scientists to help lead the way. We’re hiring new Group Leaders to join the Cellular Genomics Programme , where we decode and recode the tissue ecosystems of the human body. About the Programme: Cellular
-
post has arisen to work for 2 years (in the first instance) on a Programme grant joint between UCL, Insititute of Child Health and University of Newcastle entitled INSTINCT-MBINSTINCT MB. The work in the
-
essential. Experience with MATLAB or Python computer programming for neuroimaging data analysis is essential. Experience in MRI and/or EEG acquisition and analysis is desirable. Experience working on research
-
program. Through this work, you will build scientific independence, develop new science and leadership skills, and establish a growing reputation externally. We seek to recruit a Research Software
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic